Skip to content

Intravenous(IV) vs. Erector Spinae Plane Blocks in Cardiac Surgery

CompletedPhase 2NCT04995497
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Interfascial plane blocks have been developed for analgesia, among which the erector spinae plane (ESP) has gained popularity. The ESP block has been hypothesized to provide truncal analgesia by spread of local anesthetic into the paravertebral space. Recent studies have contested this idea showing unreliability in the spread of the local anesthetic into the paravertebral space.

Study details

Official title
IV vs. Erector Spinae Plane Blocks-Cardiac Surgery
Conditions
  • Erector Spinae Plane Block
  • Pain Control
  • Post-Operative Pain, Chronic
Interventions
  • Drug: Intravenous Administration of Lidocaine Post Cardiac Surgery
  • Drug: Administration of Lidocaine Post Cardiac Surgery via ESP Catheter
Sponsor
Archit Sharma
Organization
University of Iowa
Start date
2021-08-15
Primary completion
2023-04-07
Sex
All
Age range
from 18 Years to 80 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Undergoing elective cardiac surgery for coronary artery bypass graft (CABG) or valve surgery via sternotomy. * English speaking Exclusion Criteria: * Emergency surgery * Allergy to medications (ie lidocaine) * BMI less than 20 or greater than 50 * Major liver or kidney dysfunction or other pre-existing major organ dysfunction * Revision cardiac surgery * Surgery via thoracotomy * Off-pump coronary artery bypass * Narcotic dependent (Opioid intake morphine equivalents greater than 10mg/day for more than 3 months * Chronic pain (ie fibromyalgia) * Significant central nervous system or respiratory disease * Hematological disorders or de-ranged coagulation parameters * Psychiatric illness that impedes subject from providing informed consent * Pre-operative neurological deficits * Language barrier * Inability to provide informed consent * Prisoner status * Pregnancy

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04995497